Clinical Trials in Ávila, Spain
8 recruiting
Showing 1–10 of 10 trials
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Relapsed Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd.900 enrolled68 locationsNCT06285318
Recruiting
Impact of IBD Activity on Frailty in Patients Over 60 Years
IBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa153 enrolled34 locationsNCT06844318
Recruiting
Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Colorectal Cancer Stage IIIColorectal Cancer Stage II
BioNTech SE327 enrolled121 locationsNCT04486378
Recruiting
Phase 3
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
AbbVie698 enrolled316 locationsNCT04928846
Recruiting
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Breast Neoplasms
Spanish Breast Cancer Research Group1,867 enrolled40 locationsNCT02819882
Recruiting
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Gaucher DiseaseAcid SphingoMyelinase Deficiency
Fundación Española de Hematología y Hemoterapía210 enrolled23 locationsNCT05992532
Recruiting
Not Applicable
Comparison of Traditional and Ultrasound-Guided Techniques for Vascular Access in Patients With Difficult Venous Access in Emergency Department.
Arterial Blood PressureDifficult Vein Access
Mercedes Segunda Peralta Gámez200 enrolled1 locationNCT07013994
Recruiting
Phase 3
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled27 locationsNCT04898283
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled32 locationsNCT04891237
Recruiting
Not Applicable
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
Acute Lymphoblastic Leukemia
PETHEMA Foundation300 enrolled108 locationsNCT04179929